{
  "abstract": "The importance of innovation, research, the Life Sciences industry and collaboration with industry partners and others (joint working relationships) is seen by an National Health Service (NHS) England innovation report as key in supporting the government’s health and economic growth missions. 1 Joint working arrangements have been defined as ‘Situations where, for the benefit of patients, one or more pharmaceutical companies, the NHS and others (eg, Patient Groups) pool skills, experience and/or resources for the joint development and implementation of patient-centred projects and share a commitment to successful delivery’.2",
  "authors": [
    {
      "affiliations": [
        "Pharmacy, Royal Cornwall Hospitals NHS Trust, Truro, UK"
      ],
      "name": "Michael Wilcock"
    },
    {
      "affiliations": [
        "School of Health Policy and Management, York University - Keele Campus, Toronto, Ontario, Canada"
      ],
      "name": "Joel Lexchin"
    }
  ],
  "title": "Joint working between the NHS and pharma—do the claims add up?",
  "uid": "9f24dfad-4d50-5173-ab72-ff5ad5ac6a6a"
}